Alzheimerâs Could Lie in the Eyes of the Holder
Source: GoodLifeStudio/Getty Images
May 14, 2021
Investigators at the University of California San Francisco (UCSF) Weill Institute for Neurosciences may have found the window into understanding and potentially diagnosing Alzheimerâs disease early. New findings from the researchersâpublished recently in
Alzheimerâs & Dementia: Diagnosis, Assessment & Disease Monitoring through an article entitled âRetinal imaging demonstrates reduced capillary density in clinically unimpaired APOE ε4 gene carriersââshowed that retinal scans could detect key changes in blood vessels that may provide an early sign of Alzheimerâs while offering essential insights into how one of the most common Alzheimerâs risk genes contributes to the disease.
New Research Center to Tackle Brain Diseases
A unique combination of expertise at Gladstone Institutes and UC San Francisco will enable new therapies for Alzheimer s disease and multiple sclerosis
News provided by
Share this article
Share this article
SAN FRANCISCO, Jan. 28, 2021 /PRNewswire/ A team of scientists at Gladstone Institutes and UC San Francisco (UCSF) is launching the Gladstone-UCSF Center for Neurovascular Brain Immunology to study neurological diseases in a unique way that could lead to the development of novel treatments. This launch is supported by a $2.5-million donation from the Simon Family Trust.
Katerina Akassoglou will lead the new Gladstone-UCSF Center for Neurovascular Brain Immunology, which brings together a unique combination of expertise to enable novel therapies for Alzheimer’s disease and multiple sclerosis.